A 33-year-old woman was transferred to our hospital for an unresolving pneumonia, who initially presented with dyspnea. Initially antibiotic therapy was started under the suspicion of community-acquired pneumonia, however, her respiratory status worsened at the previous hospital. Computed tomography (CT) on presentation showed peripheral ground glass opacities in both sides of the upper lobe. Also despite additional prednisolone therapy, her respiratory status worsened. On admission to our hospital, physical examination showed Gottoron's sign in her right elbow. From the nature of the rash, the absence of myositis symptoms and rapid respiratory worsening, we suspected clinically amyopathic dermatomyositis (CADM). After the triple drug therapy, her respiratory status improved.
lymph node swelling, sputum, palpitations, edema, or arthralgia.
Past medical history included endometriosis that was well controlled without medication, and her menstrual cycle tended to be prolonged. She had no significant family history. She did not smoke or drink alcohol. She had no known allergies. She denied any exposures to sick persons including those with tuberculosis, farm or domestic animals and birds, and mosquito or tick bites, and she had not travelled recently. Last year she moved to a newly-built condominium. She denied sexual history.
Dyspnea is defined as an abnormally uncomfortable awareness of breathing, commonly seen in the primary care setting; 1 its intensity is quantified by establishing the amount of physical exertion necessary to produce the sensation.
In a setting of a one-month history of dyspnea which is refractory to antibiotics with chest X-ray infiltration shadows, there are multiple possibilities to note cardiovascular disease (such as chronic pulmonary embolism, infective endocarditis, congestive heart failure), infections (such as mycobacterium infection, pneumocystis pneumonia), drug induced pneumonia and autoimmune diseases (such as chronic hypersensitivity pneumonitis, chronic eosinophilic pneumo- It is important to distinguish dyspnea due to pulmonary diseases from other organ diseases. Bilateral fine crackles are associated with various diseases (e.g., ILD, congestive heart failure, pneumonia), can be the earliest sign of disease (e.g., idiopathic pulmonary fibrosis, asbestosis), and may be present before detection of changes on radiological examination. 2 The setting of a three-month history of symptoms suggests ILD (i.e. interstitial lung disease).
Otherwise, given other nonspecific physical examination findings above lowers the possibility of cardiovascular disease, connective tissue disease, and vasculitis. There were no manifestations indicative of collagen diseases, such as arthritis or eruptions, at that time. The periungual erythema was not considered as a specific symptom associated with connective tissue diseases at the time through a discussion with a dermatologist, and she was treated with difluprednate.
Laboratory data are shown in Table 1 . The white blood cell count was 8,800/µL. Serum creatinine kinase was antigens were all negative. The chest radiograph on admission revealed bilateral reticular shadows adjacent to the pleura ( Figure 1A ).
Chest CT ( Figure 1B and Figure 1C ) showed randomized peripheral ground glass opacities and consolidation of both lower lungs.
Laboratory data did not show eosinophilia or renal dysfunction. Random peripheral ground glass opacities and consolidation appeared in both lower peripheral lungs, which suggested an organizing pneumonia pattern. Based on the CT pattern, tuberculosis, pneumocystis pneumonia, pulmonary edema, and sarcoidosis were less likely. The relative and absolute cell counts findings in bronchoalveolar lavage (BAL) fluid is sometimes useful in a variety of ILD. Figure 2A ). Painful periungual erythema was observed in all fingers ( Figure 2B) . A scaly erythematous eruption at the right elbow was found, which was highly suggestive of Gottron's papule ( Figure 2C ).
The eyelid swelling without pruritus suggests a heliotrope rash. The scaly erythematous eruption at the right elbow is often seen in dermatomyositis.
Since the patient developed acute progressive respiratory failure with ILD, dermatological manifestations of dermatomyositis without muscle symptoms and a normal muscle enzyme level, clinically amyopathic dermatomyositis (CADM) was suspected.
CADM is characterized by cutaneous manifestations of classical DM occurring for 6 months or longer with no clinical evidence of proximal muscle weakness. 4 Although the duration was less than 6 months, it was decided to start treatment for CADM because of the patient's severe respiratory status. The anti-MDA5 (CADM-140) antibody is considered to be useful as a specific serological marker for Every two-week 750 mg/body cyclophosphamide therapy was given a total of 8 times, and prednisolone was gradually tapered in parallel. Her respiratory status finally improved so that oxygen therapy was not necessary, and she was discharged on the 139th hospital day.
Discussion
This was a case of a 33-year-old woman with rapidly progressive dyspnea caused by ILD with periungual erythema that turned out to be CADM. CADM encompasses both the amyopathic and hypomyopathic DM groups and predominant clinical problem of CADM is protracted skin disease.
The prevalence of CADM within the DM population is not clear. In the only small retrospective populationbased study, 21% of DM patients had CADM. 6 A typical clinical picture of ILD in DM is mild, chronic, and non-progressive course with immunosuppressive treatment, 7 while rapidly progressive ILD can occur in some cases. The proportion of rapidly progressive ILD secondary to CADM is unknown. In Asia, the prevalence of rapidly progressive ILD in CADM may be higher than in other countries and that may be related to increased mortality, despite a lack of direct comparisons. 8 According to a study in Japan, DM patients with normal CPK levels showed poor prognosis since they developed corticosteroid-resistant ILD. 9 The prognosis of ILD in CADM patients also varies with type of antibodies. Anti-aminoacyl transfer RNA Figure 2 .
synthetase (ARS) antibody is a major myositis-specific autoantibody and is useful for the diagnosis of polymyositis and dermatomyositis (PM/DM). ILD has common pulmonary manifestations in patients who are anti-ARS antibody-positive and it has a good response to steroid therapy. 10 On the other hand, anti-melanoma differentiationassociated gene 5 (MDA5) antibody (anti-CADM-140 antibody) is also one of the myositis-specific autoantibodies and is associated with a fatal outcome due to acute progressive ILD. 11 Anti-MDA5 antibody is relatively specific, seen in 40-70% of CADM cases, while its presence is relatively uncommon (0-10%) in classic DM, 12 and it is useful for the early diagnosis of ILD with DM. Hyperferritinemia is a factor that can be used to predict disease severity and prognosis for anti-MDA5 antibody-positive patients, especially when the ferritin level is over 1600 ng/mL. 13 The predominant patterns in the chest CT findings of anti-MDA5 antibody-positive cases were lower consolidation or ground-glass attenuation (GGA) pattern (50.0%) and random GGA pattern (33.3%). They were also well characterized by the absence of intralobular reticular opacities. 14 The best therapy for CADM has not yet been established, but early combined immunosuppressive therapy with high-dose prednisolone (PSL) and intravenous pulse cyclophosphamide every 3-4 weeks has been pointed out to be more effective than high-dose PSL and one immunosuppressive agent. 15 It is important to diagnose CADM in its early stage because of its poor prognosis. However, in the present case, the underestimation of the importance of the periungual erythema and the late appearance of Gottron's papules delayed the diagnosis. There have been few studies of the nail changes of PM/DM, hence the diagnostic value of periungual erythema in the setting of CADM is unclear. According to a casecontrol study in Turkey, splinter hemorrhages and capillary loops in the proximal nail fold in fingernails are significantly frequent in PM/DM patients, but the prevalence of periungual erythema remains obscure. 16 However, periungual erythema had a high specificity for systemic lupus erythematosus in this study, and there were no cases in the control group without connective tissue disease with periungual erythema.
Thus, periungual erythema should be considered as a meaningful sign.
From the other reports, heliotrope erythema, Gottron's papules, and periungual erythema were the most frequent skin lesions; 17 15% of patients with dermatomyositis show atypical skin lesions.
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In anti-MDA5-positive cases, it is characteristic to have skin ulceration, tender palmar papules, or both. Typical areas of skin ulceration include lateral nail folds and elbows. In some cases, erythema is also shown on the upper eyelids, fingers and elbows. 19 Patients also had an increased risk of oral soreness and/or ulceration, hand swelling, arthritis/arthralgia, and diffuse hair loss. 20 
Conclusion
This case was a challenging example in diagnosing CADM that progressive respiratory failure with ILD and periungual erythema might be a clue for the diagnosis. Whenever acute or subacute ILD is found, it is pivotal to examine carefully for skin changes and if those exist, consider CADM with positive anti-CADM-140 antibody.
